Pimobendan improves right ventricular myocardial contraction and attenuates pulmonary arterial hypertension in rats with monocrotaline-induced pulmonary arterial hypertension

被引：0
|
作者：
Rieko Yoshiyuki
Telma Mary Nakata
Toshiharu Fukayama
Lina Hamabe
Hsu Huai-Che
Shuji Suzuki
Noboru Machida
Ryuji Fukushima
Ryou Tanaka
机构：
[1] Tokyo University of Agriculture and Technology,Department of Veterinary Surgery, Faculty of Agriculture
[2] Tokyo University of Agriculture and Technology,Department of Veterinary Clinical Oncology, Faculty of Agriculture
来源：
Journal of Medical Ultrasonics | 2014年 / 41卷
关键词：
Monocrotaline; Pimobendan; Pulmonary hypertension; Rat; Right ventricular hypertrophy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：173 / 180
页数：7
相关论文
共 50 条
  • [31] Astragalus Polysaccharides Attenuate Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Yuan, Lin-Bo
    Hua, Chun-Yan
    Gao, Sheng
    Yin, Ya-Ling
    Dai, Mao
    Meng, Han-Yan
    Li, Piao-Piao
    Yang, Zhong-Xin
    Hu, Qing-Hua
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2017, 45 (04): : 773 - 789
  • [32] Pathophysiological Role of Dexmedetomidine for Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
    Yamaguchi, Yohei
    Hosokawa, Susumu
    Kajikawa, Yusuke
    Maejima, Yasuhiro
    Isobe, Mitsuaki
    Furukawa, Tetsushi
    Doi, Shozaburo
    CIRCULATION, 2020, 142
  • [33] Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
    Wu, Yonghui
    Cai, Changhong
    Yang, Lebing
    Xiang, Yijia
    Zhao, Huan
    Zeng, Chunlai
    MOLECULAR MEDICINE REPORTS, 2020, 21 (03) : 1192 - 1200
  • [34] Effects of atorvastatin and losartan on monocrotaline-induced pulmonary arterial hypertension in rats
    Lin, P. S.
    Xie, H.
    Xie, L. D.
    Xu, C. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 : S49 - S50
  • [35] Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats
    Tang, Chao
    Luo, Yunmei
    Li, Sha
    Huang, Bo
    Xu, Shangfu
    Li, Lisheng
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [36] Ethyl Pyruvate Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Liu, Chuanzhen
    Fang, Changcun
    Cao, Guangqing
    Liu, Kai
    Wang, Biao
    Wan, Zhaojie
    Li, Sijie
    Wu, Shuming
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (01) : 7 - 15
  • [37] Cardiac Glycolytic Metabolism In Monocrotaline-Induced Pulmonary Arterial Hypertension Rats
    Qiu, M. -H.
    Zhang, R.
    Zhang, H. -D.
    Jiang, X.
    Liu, D.
    Jing, Z. -C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [38] Changes in the right ventricular function of rats with monocrotaline-induced pulmonary hypertension
    Daicho, Takuya
    Tanonaka, Kouichi
    Yagi, Tatsuya
    Takano, Saori
    Takeo, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 196P - 196P
  • [39] Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats
    Bi, Li-Qing
    Zhu, Rong
    Kong, Hui
    Wu, Su-Ling
    Li, Nan
    Zuo, Xiang-Rong
    Zhou, Su-Ming
    Kou, Jun-Ping
    Yu, Bo-Yang
    Wang, Hong
    Xie, Wei-Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 16 (01) : 7 - 16
  • [40] Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway
    Gao, Hua
    Cheng, Yuqing
    Zong, Liguo
    Huang, Linian
    Qiao, Chenchen
    Li, Wei
    Gong, Beilei
    Hu, Junfeng
    Liu, Haitao
    Wang, Xiaojing
    Zhao, Chengling
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2017, 39 (01) : 34 - 41
12345